Search for occult malignancy in patients with deep venous thrombosis

Swiss Medical Weekly

Volumn 133, Issue 41-42, 2003, Pages 567-574

  Ronsdorf, Anke ^a,c   Perruchoud, André P ^a   Schoenenberger, Ronald A ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Buergerspital   (Switzerland)

^c Kantonsspital Liestal   (Switzerland)

Author keywords

Abdominal ultrasound; Deep venous thrombosis; Occult cancer; Safe limited screening

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CLINICAL EXAMINATION; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; KIDNEY CANCER; LABORATORY TEST; LUNG CANCER; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; PREVALENCE; PROSTATE CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; THYROID CANCER;

EID: 0344630182     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Trousseau A. Phlegmasia alba dolens. In: Clinique Médicale de l'Hotel-Dieu de Paris. 2nd ed. Paris: JB Bailliere 1865;3:654-712.
2. Prins MH, Lensing AWA, Hirsh J. Idiopathic deep venous thrombosis. Is search for malignant disease justified? Arch Intern Med 1994;154:1310-12.
3. Monreal M, Prandoni P. Venous thromboembolism as first manifestation of cancer. Sem Thromb Haemost 1999;25(2): 131-6.
4. Prandoni P, Piccioli A, Girolami A. Cancer and venous thromboemblism: an overview. Haematologica 1999;84:437-45.
5. Prandoni P. Cancer and thromboembolic disease: how important is the risk of thrombosis? Cancer Treat Rev 2002;28(3):133-6.
6. Fennerty T. Screening for cancer in venous thromboembolic disease. Brit Med J 2001;323:704-5.
7. Sörensen HT. Screening for cancer in patients with venous thromboembolism. Haemostasis 2001;31(Suppl 1):34-6.
8. Alatri A, Carnovali M, Prandoni P. Venous thromboembolism and neoplasms. Ann Iral Med Int 2000;15:156-65.
9. Otten HM, Prins MH. Venous thromboembolism and occult malignancy. Thromb Res 2001;102:V187-94.
10. Rickles FR, Levine MN. Venous thromboembolism in malignancy and malignancy in venous thromboembolism. Haemostasis 1998;28(Suppl 3):43-9.
11. Rickles FR, Levine MN. Epidemiology of thrombosis in cancer. Acta Haematol 2001;106:6-12.
12. Piccioli A, Prandoni P. Venous thromboembolism as first manifestation of cancer. Acta Haematol 2001;106:13-7.
13. Girolami A, Idiopathic deep vein thrombosis and subsequent cancer: suggestions for a patient-oriented approach. Clin Appl Thromb Hemost 2001;7:321-4.
14. Announcement: Screening for occult malignant disease in patients with symptomatic idiopathic venous thromboembolism. Thromb Haemost 1992;68:783.
15. Piccioli A, Prandoni P. Idiopathic venous thromboembolism as a first manifestation of cancer. Haemostasis 2001;31(Suppl 1): 37-9.
16. Otten HM, Prins MH. A number needed to screen and cost-effectiveness analysis of the SOMIT-data. Haemostasis 2001;31(Suppl 1):40-2.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
18. Aderka D, Brown A, Zelikovski A, Pinkhas J. Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitoring sign of occult cancer. Cancer 1986;57:1846-9.
19. Goldberg RJ, Seneff M, Gore JM, Anderson FA Jr, Greene HL, Wheeler HB, Dalen JE. Occult malignant neoplasm in patients with deep vein thrombosis. Arch Intern Med 1987;147:251-3.
20. Prandoni P, Lensing AWA, Büller HR, Cogo A, Prins MH, Cattelan AM, et al. Deep vein thrombosis and the incidence of subsequent symptomatic malignant disease. N Engl J Med 1992;327:1128-33.
21. Bastounis EA, Karayiannakis AJ, Makri GG, Alexiou D, Papalambros EL. The incidence of occult cancer in patients with deep venous thrombosis: a prospective study. J Intern Med 1996;239:153-6.
22. Soerensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998;338:1169-73.
23. Monreal M, Lafoz E, Casals A, Inaraja L, Montserrat E, Callejas JM, Martorell A. Occult cancer in patients with deep vein thrombosis. A systematic approach. Cancer 1991;67:541-5.
24. Ranft J, Heidrich H. Frequency of malignant diseases in deep venous thrombosis of the lower extremities. Intern Angiology 1991;10:66-8.
25. Chraibi S, Bennis A, Kemmou O, Fadouach S, Tahiri A, Chraibi N. Deep venous thromboses and occult cancers. Ann Cardiol Angiol 1997;46:145-9.
26. Cornuz J, Pearson SD, Creager MA, Cook EF, Goldman L. Importance of findings on the initial evaluation for cancer in patients with symptomatic deep venous thrombosis. Ann Int Med 1996;125:785-93.
27. Craido E, Burnham CB. Predictive value of clinical criteria for the diagnosis of deep vein thrombosis. Surgery 1997;122:578-83.
28. Anlyan WG, Shingleton WW, De Laughter GD. Significance of idiopathic thrombosis and hidden cancer. JAMA 1956;161:964-5.
29. Rance Á, Emmerich J, Guedl C, Fiessinger JN. Occult cancer in patients with bilateral deep-vein thrombosis. Lancet 1997;350:1448-9.
30. Monreal M, Casals A. Boix J, Olazabal A, Montserrat E, Mundo MR. Occult cancer in patients with acute pulmonary embolism. A prospective study. Chest 1993;103:816-9.
31. Monreal M, Salvador R, Soriano V, Sabria M. Cancer and deep venous thrombosis. Arch Intern Med 1988;148:485.
32. Monreal M, Fernandez-Llamazares J, Perandreu J, Urrutia A, Sahuquillo JC, Contel E. Occult cancer in patients with venous thromboembolism: which patients, which cancers? Thromb Haemost 1997;78:1316-8.
33. Hettiarachchi RJK, Lok J, Prins MH, Büller HR, Prandoni P. Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators and diagnosis. Cancer 1998;83:180-5.
34. Rajan R, Levine M, Gent M, Hirsh J, Geerts W, Skingley P, et al. The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort study. Thromb Haemost 1998;79:19-22.
35. Chenu E, Guias B, Mottier D, Leroyer C. What investigations should be done following the first episode of pulmonary embolism? Rev Mal Resp 1999;16:1007-17.
36. Prins MH, Lensing AWA, Hirsh J. Idiopathic deep venous thrombosis. Is search for malignant disease justified? Arch Intern Med 1994;154:1310-2.
37. Prins MH, Hettiarachchi RJK, Lensing AWA, Hirsh J. Newly diagnosed malignancy in patients with venous thromboembolism. Search or wait and see? Thromb Haemost 1997;78:121-5.
38. Cailleux N, Marie I, Primard E, Lecomte F, Henry J, Ouvel JP, et al. Thrombophlebitis and cancer: evaluation of the diagnostic value of abdominal ultrasonography in the acute phase of a deep vein thrombosis. Report of 148 consecutive examinations. J Mal Vasc 1997;22:322-5.
39. Netzer P, Binek J, Hammer B, Schmassmann A. Utility of abdominal sonography in patients with idiopathic deep venous thrombosis. J Clin Ultrasound 1999;27:177-81.
40. Fahrig C, Heidrich H, Penninger C. The incidence of occult malignant diseases in patients with deep venous thrombosis of the pelvis and lower limb. Intern J Angiology 1998;7:249-51.
41. Nordstroem M, Lindblad B, Anderson H, Bergqvist D, Kjellstroem T. Deep venous thrombosis and occult malignancy: an epidemiological study. Brit Med J 1994;308:891-4.
42. Baron JA, Gridley G, Weiderpass E, Nyrén O, Linet M. Venous thromboembolism and cancer. Lancet 1998;351:1077-80.
43. Schulman S, Lindmarker P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. N Engl J Med 2000;342:1953-8.
44. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;343:1846-50.